Daily Newsletter

12 August 2024

Daily Newsletter

12 August 2024

Origin Materials and Reed City Group to mass-produce PET caps and closures

The first products made with either virgin or rPET are set to be available from Q4 2024.

Jangoulun Singsit August 09 2024

Origin Materials has partnered with Reed City Group, a full-scale injection-mould builder, to mass-produce polyethylene terephthalate (PET) caps and closures in North America. 

The partnership is set to establish commercial manufacturing lines for Origin's PET caps and closures at Reed City Group's Michigan, US, facilities.  

The manufacturing lines will be equipped to process both virgin and recycled PET (rPET) using high-speed equipment and automation.  

Origin co-CEO and co-founder John Bissell said: "Together with Reed City Group we expect to begin mass production of PET caps for the North American region later this year. 

“We look forward to partnering with the Reed City Group team of over 200 people including skilled machinists, mechanical engineers, and operations professionals, with impressive capabilities in tool making and clean room manufacturing. 

"Our Reed City Group partnership enables a geographic expansion complementary to our previously announced mass-production capability based in Europe.” 

Origin's PET caps and closures are designed to improve recyclability, including through cap tethering, addressing a market worth more than $65bn.  

The first products, Origin’s PCO 1881-compatible caps made with either virgin or rPET, are expected to be available from the fourth quarter (Q4) of 2024, with tethered caps and other types to follow.  

Reed City Group CEO Guy Boitos said: “Our company has a longstanding commitment to innovation and bringing our two companies together to fulfil the market needs of sustainable products is a natural fit. We are eager to partner with Origin for this transformative project for years to come.” 

Recently, Origin Materials unveiled the engineering and design of its tethered PET cap solution.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Pharmaceutical Packaging Market Overview

GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close